A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone

NCT00234169 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Lymphoma

Interventions

DRUG: VTP195183

Sponsor

Peter MacCallum Cancer Centre, Australia

Collaborators

[object Object]